Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Diabetes

  Free Subscription


Articles published in J Am Soc Nephrol

Retrieve available abstracts of 56 articles:
HTML format



Single Articles


    July 2021
  1. MYCHALECKYJ J, Valo E, Ichimura T, Ahluwalia T, et al
    Association of Coding Variants in Hydroxysteroid 17-beta Dehydrogenase 14 (HSD17B14) with Reduced Progression to End Stage Kidney Disease in Type 1 Diabetes.
    J Am Soc Nephrol. 2021 Jul 14. pii: ASN.2020101457. doi: 10.1681/ASN.2020101457.
    PubMed     Abstract available


    June 2021
  2. SATAKE E, Saulnier PJ, Kobayashi H, Gupta M, et al
    Comprehensive Search for Novel Circulating miRNAs and Axon Guidance Pathway Proteins Associated with Risk of End Stage Kidney Disease in Diabetes.
    J Am Soc Nephrol. 2021 Jun 17. pii: ASN.2021010105. doi: 10.1681/ASN.2021010105.
    PubMed     Abstract available


    April 2021
  3. HYNDMAN KA, Griffin MD
    Could NAD(+) Precursor Supplements Induce a Legacy of Protection against Diabetic Nephropathy?
    J Am Soc Nephrol. 2021 Apr 14. pii: ASN.2021020275. doi: 10.1681/ASN.2021020275.
    PubMed    


  4. WALTHER CP, Winkelmayer WC, Navaneethan SD
    Black Race Coefficient in GFR Estimation and Diabetes Medications in CKD: National Estimates.
    J Am Soc Nephrol. 2021 Apr 8. pii: ASN.2020121724. doi: 10.1681/ASN.2020121724.
    PubMed    


  5. YASUDA I, Hasegawa K, Sakamaki Y, Muraoka H, et al
    Pre-emptive Short-term Nicotinamide Mononucleotide Treatment in a Mouse Model of Diabetic Nephropathy.
    J Am Soc Nephrol. 2021 Apr 1. pii: ASN.2020081188. doi: 10.1681/ASN.2020081188.
    PubMed     Abstract available


    March 2021
  6. PETRILLO F, Iervolino A, Angrisano T, Jelen S, et al
    Dysregulation of Principal Cell miRNAs Facilitates Epigenetic Regulation of AQP2 and Results in Nephrogenic Diabetes Insipidus.
    J Am Soc Nephrol. 2021 Mar 16. pii: ASN.2020010031. doi: 10.1681/ASN.2020010031.
    PubMed     Abstract available


    January 2021
  7. SHETTY AA, Tawhari I, Safar-Boueri L, Seif N, et al
    COVID-19-Associated Glomerular Disease.
    J Am Soc Nephrol. 2021;32:33-40.
    PubMed     Abstract available


  8. WEN Y, Parikh CR
    The Aftermath of AKI: Recurrent AKI, Acute Kidney Disease, and CKD Progression.
    J Am Soc Nephrol. 2021;32:2-4.
    PubMed    


    December 2020
  9. OSHIMA M, Neuen BL, Li J, Perkovic V, et al
    Early Change in Albuminuria with Canagliflozin Predicts Kidney and Cardiovascular Outcomes: A Post Hoc Analysis from the CREDENCE Trial.
    J Am Soc Nephrol. 2020;31:2925-2936.
    PubMed     Abstract available


    October 2020
  10. SCHRAUBEN SJ, Shou H, Zhang X, Anderson AH, et al
    Association of Multiple Plasma Biomarker Concentrations with Progression of Prevalent Diabetic Kidney Disease: Findings from the Chronic Renal Insufficiency Cohort (CRIC) Study.
    J Am Soc Nephrol. 2020 Oct 29. pii: ASN.2020040487. doi: 10.1681/ASN.2020040487.
    PubMed     Abstract available


  11. OSHIMA M, Neal B, Toyama T, Ohkuma T, et al
    Different eGFR Decline Thresholds and Renal Effects of Canagliflozin: Data from the CANVAS Program.
    J Am Soc Nephrol. 2020;31:2446-2456.
    PubMed     Abstract available


    September 2020
  12. HAPCA S, Siddiqui MK, Kwan RSY, Lim M, et al
    The Relationship between AKI and CKD in Patients with Type 2 Diabetes: An Observational Cohort Study.
    J Am Soc Nephrol. 2020 Sep 18. pii: ASN.2020030323. doi: 10.1681/ASN.2020030323.
    PubMed     Abstract available


    August 2020
  13. TUOT DS
    Improving Equity in Medication Use through Better Kidney Function Measurement.
    J Am Soc Nephrol. 2020;31:1657-1658.
    PubMed    


  14. SHIN JI, Sang Y, Chang AR, Dunning SC, et al
    The FDA Metformin Label Change and Racial and Sex Disparities in Metformin Prescription among Patients with CKD.
    J Am Soc Nephrol. 2020;31:1847-1858.
    PubMed     Abstract available


    July 2020
  15. MADHUSUDHAN T, Ghosh S, Wang H, Dong W, et al
    Podocyte Integrin-beta 3 and Activated Protein C Coordinately Restrict RhoA Signaling and Ameliorate Diabetic Nephropathy.
    J Am Soc Nephrol. 2020 Jul 24. pii: ASN.2019111163. doi: 10.1681/ASN.2019111163.
    PubMed     Abstract available


  16. FERGUSON R, Leatherman S, Fiore M, Minnings K, et al
    Prevalence and Risk Factors for CKD in the General Population of Southwestern Nicaragua.
    J Am Soc Nephrol. 2020;31:1585-1593.
    PubMed     Abstract available


    June 2020
  17. MOTRAPU M, Swiderska MK, Mesas I, Marschner JA, et al
    Drug Testing for Residual Progression of Diabetic Kidney Disease in Mice Beyond Therapy with Metformin, Ramipril, and Empagliflozin.
    J Am Soc Nephrol. 2020 Jun 23. pii: ASN.2019070703. doi: 10.1681/ASN.2019070703.
    PubMed     Abstract available


  18. NICHOLS GA, Ustyugova A, Deruaz-Luyet A, O'Keeffe-Rosetti M, et al
    Health Care Costs by Type of Expenditure across eGFR Stages among Patients with and without Diabetes, Cardiovascular Disease, and Heart Failure.
    J Am Soc Nephrol. 2020 Jun 2. pii: ASN.2019121308. doi: 10.1681/ASN.2019121308.
    PubMed     Abstract available


  19. CHENG Y, Wang D, Wang F, Liu J, et al
    Endogenous miR-204 Protects the Kidney against Chronic Injury in Hypertension and Diabetes.
    J Am Soc Nephrol. 2020 Jun 2. pii: ASN.2019101100. doi: 10.1681/ASN.2019101100.
    PubMed     Abstract available


    May 2020
  20. LI YJ, Chen X, Kwan TK, Loh YW, et al
    Dietary Fiber Protects against Diabetic Nephropathy through Short-Chain Fatty Acid-Mediated Activation of G Protein-Coupled Receptors GPR43 and GPR109A.
    J Am Soc Nephrol. 2020 May 1. pii: ASN.2019101029. doi: 10.1681/ASN.2019101029.
    PubMed     Abstract available


  21. JARDINE MJ, Zhou Z, Mahaffey KW, Oshima M, et al
    Renal, Cardiovascular, and Safety Outcomes of Canagliflozin by Baseline Kidney Function: A Secondary Analysis of the CREDENCE Randomized Trial.
    J Am Soc Nephrol. 2020;31:1128-1139.
    PubMed     Abstract available


  22. NAKAGAWA T, Johnson RJ, Andres-Hernando A, Roncal-Jimenez C, et al
    Fructose Production and Metabolism in the Kidney.
    J Am Soc Nephrol. 2020;31:898-906.
    PubMed     Abstract available


    April 2020
  23. PACKER M
    Role of Impaired Nutrient and Oxygen Deprivation Signaling and Deficient Autophagic Flux in Diabetic CKD Development: Implications for Understanding the Effects of Sodium-Glucose Cotransporter 2-Inhibitors.
    J Am Soc Nephrol. 2020 Apr 10. pii: ASN.2020010010. doi: 10.1681/ASN.2020010010.
    PubMed     Abstract available


    March 2020
  24. MARSHALL MR, Vandal AC, de Zoysa JR, Gabriel RS, et al
    Effect of Low-Sodium versus Conventional Sodium Dialysate on Left Ventricular Mass in Home and Self-Care Satellite Facility Hemodialysis Patients: A Randomized Clinical Trial.
    J Am Soc Nephrol. 2020 Mar 18. pii: ASN.2019090877. doi: 10.1681/ASN.2019090877.
    PubMed     Abstract available


    January 2020
  25. SUGAHARA M, Tanaka S, Tanaka T, Saito H, et al
    Prolyl Hydroxylase Domain Inhibitor Protects against Metabolic Disorders and Associated Kidney Disease in Obese Type 2 Diabetic Mice.
    J Am Soc Nephrol. 2020 Jan 29. pii: ASN.2019060582. doi: 10.1681/ASN.2019060582.
    PubMed     Abstract available


  26. PIERI M
    Hypothesis as to How a Common Missense Mutation in COL4A3 May Confer Protection against Diabetic Kidney Disease.
    J Am Soc Nephrol. 2020 Jan 27. pii: ASN.2019090966. doi: 10.1681/ASN.2019090966.
    PubMed    


  27. GUO J, Rackham OJL, Sandholm N, He B, et al
    Whole-Genome Sequencing of Finnish Type 1 Diabetic Siblings Discordant for Kidney Disease Reveals DNA Variants associated with Diabetic Nephropathy.
    J Am Soc Nephrol. 2020 Jan 9. pii: ASN.2019030289. doi: 10.1681/ASN.2019030289.
    PubMed     Abstract available


    December 2019
  28. RULE AD, Jager KJ, van den Brand JAJG, Delanaye P, et al
    Chronic Kidney Disease: Call for an Age-Adapted Definition.
    J Am Soc Nephrol. 2019 Dec 23. pii: ASN.2019111188. doi: 10.1681/ASN.2019111188.
    PubMed    


    October 2019
  29. SEDOR JR, Freedman BI
    Biologic Underpinnings of Type 1 Diabetic Kidney Disease.
    J Am Soc Nephrol. 2019;30:1782-1783.
    PubMed    


  30. LEMLEY KV
    Machine Learning Comes to Nephrology.
    J Am Soc Nephrol. 2019;30:1780-1781.
    PubMed    


    September 2019
  31. DE GROOT T, Ebert LK, Christensen BM, Andralojc K, et al
    Identification of Acer2 as a First Susceptibility Gene for Lithium-Induced Nephrogenic Diabetes Insipidus in Mice.
    J Am Soc Nephrol. 2019 Sep 26. pii: ASN.2018050549. doi: 10.1681/ASN.2018050549.
    PubMed     Abstract available


  32. SALEM RM, Todd JN, Sandholm N, Cole JB, et al
    Genome-Wide Association Study of Diabetic Kidney Disease Highlights Biology Involved in Glomerular Basement Membrane Collagen.
    J Am Soc Nephrol. 2019 Sep 19. pii: ASN.2019030218. doi: 10.1681/ASN.2019030218.
    PubMed     Abstract available


  33. CHERTOW GM, Pergola PE, Chen F, Kirby BJ, et al
    Effects of Selonsertib in Patients with Diabetic Kidney Disease.
    J Am Soc Nephrol. 2019 Sep 10. pii: ASN.2018121231. doi: 10.1681/ASN.2018121231.
    PubMed     Abstract available


  34. GINLEY B, Lutnick B, Jen KY, Fogo AB, et al
    Computational Segmentation and Classification of Diabetic Glomerulosclerosis.
    J Am Soc Nephrol. 2019 Sep 5. pii: ASN.2018121259. doi: 10.1681/ASN.2018121259.
    PubMed     Abstract available


    August 2019
  35. KIM SJ, Gill JS, Knoll G, Campbell P, et al
    Referral for Kidney Transplantation in Canadian Provinces.
    J Am Soc Nephrol. 2019 Aug 6. pii: ASN.2019020127. doi: 10.1681/ASN.2019020127.
    PubMed     Abstract available


    June 2019
  36. LOOKER HC, Mauer M, Saulnier PJ, Harder JL, et al
    Changes in Albuminuria But Not GFR are Associated with Early Changes in Kidney Structure in Type 2 Diabetes.
    J Am Soc Nephrol. 2019;30:1049-1059.
    PubMed     Abstract available


    May 2019
  37. SUGAHARA S, Kume S, Chin-Kanasaki M, Tomita I, et al
    Protein O-GlcNAcylation Is Essential for the Maintenance of Renal Energy Homeostasis and Function via Lipolysis during Fasting and Diabetes.
    J Am Soc Nephrol. 2019 May 1. pii: ASN.2018090950. doi: 10.1681/ASN.2018090950.
    PubMed     Abstract available


    April 2019
  38. SAKAI S, Yamamoto T, Takabatake Y, Takahashi A, et al
    Proximal Tubule Autophagy Differs in Type 1 and 2 Diabetes.
    J Am Soc Nephrol. 2019 Apr 30. pii: ASN.2018100983. doi: 10.1681/ASN.2018100983.
    PubMed     Abstract available


    March 2019
  39. ISHIZAWA K, Wang Q, Li J, Xu N, et al
    Inhibition of Sodium Glucose Cotransporter 2 Attenuates the Dysregulation of Kelch-Like 3 and NaCl Cotransporter in Obese Diabetic Mice.
    J Am Soc Nephrol. 2019 Mar 26. pii: ASN.2018070703. doi: 10.1681/ASN.2018070703.
    PubMed     Abstract available


  40. CARLSTROM M
    The Other Glucose Transporter, SGLT1 - Also a Potential Trouble Maker in Diabetes?
    J Am Soc Nephrol. 2019 Mar 13. pii: ASN.2019020171. doi: 10.1681/ASN.2019020171.
    PubMed    


  41. HONG Q, Zhang L, Fu J, Verghese DA, et al
    LRG1 Promotes Diabetic Kidney Disease Progression by Enhancing TGF-beta-Induced Angiogenesis.
    J Am Soc Nephrol. 2019 Mar 11. pii: ASN.2018060599. doi: 10.1681/ASN.2018060599.
    PubMed     Abstract available


  42. FU J, Akat KM, Sun Z, Zhang W, et al
    Single-Cell RNA Profiling of Glomerular Cells Shows Dynamic Changes in Experimental Diabetic Kidney Disease.
    J Am Soc Nephrol. 2019 Mar 7. pii: ASN.2018090896. doi: 10.1681/ASN.2018090896.
    PubMed     Abstract available


    October 2018
  43. ZHANG Y, Ma KL, Gong YX, Wang GH, et al
    Platelet Microparticles Mediate Glomerular Endothelial Injury in Early Diabetic Nephropathy.
    J Am Soc Nephrol. 2018 Oct 19. pii: ASN.2018040368. doi: 10.1681/ASN.2018040368.
    PubMed     Abstract available


  44. WANNER C, Heerspink HJL, Zinman B, Inzucchi SE, et al
    Empagliflozin and Kidney Function Decline in Patients with Type 2 Diabetes: A Slope Analysis from the EMPA-REG OUTCOME Trial.
    J Am Soc Nephrol. 2018 Oct 12. pii: ASN.2018010103. doi: 10.1681/ASN.2018010103.
    PubMed     Abstract available


    September 2018
  45. ERIGUCHI M, Bernstein EA, Veiras LC, Khan Z, et al
    The Absence of the ACE N-Domain Decreases Renal Inflammation and Facilitates Sodium Excretion during Diabetic Kidney Disease.
    J Am Soc Nephrol. 2018 Sep 5. pii: ASN.2018030323. doi: 10.1681/ASN.2018030323.
    PubMed     Abstract available


    May 2018
  46. ILATOVSKAYA DV, Blass G, Palygin O, Levchenko V, et al
    A NOX4/TRPC6 Pathway in Podocyte Calcium Regulation and Renal Damage in Diabetic Kidney Disease.
    J Am Soc Nephrol. 2018 May 23. pii: ASN.2018030280. doi: 10.1681/ASN.2018030280.
    PubMed     Abstract available


    April 2018
  47. HICKSON LJ, Balls-Berry JE, Jaffe AS, Rule AD, et al
    Biomarkers Associated with Progression of Diabetic Kidney Disease: Do They Hold the Same Meaning for Blacks and Women?
    J Am Soc Nephrol. 2018 Apr 20. pii: ASN.2017121249. doi: 10.1681/ASN.2017121249.
    PubMed    


  48. MA X, Schwarz A, Sevilla SZ, Levin A, et al
    Depletion of Gprc5a Promotes Development of Diabetic Nephropathy.
    J Am Soc Nephrol. 2018 Apr 10. pii: ASN.2017101135. doi: 10.1681/ASN.2017101135.
    PubMed     Abstract available


    March 2018
  49. ZHONG F, Chen H, Xie Y, Azeloglu EU, et al
    Protein S Protects against Podocyte Injury in Diabetic Nephropathy.
    J Am Soc Nephrol. 2018 Mar 6. pii: ASN.2017030234. doi: 10.1681/ASN.2017030234.
    PubMed     Abstract available


    February 2018
  50. BRENNAN EP, Mohan M, McClelland A, Tikellis C, et al
    Lipoxins Regulate the Early Growth Response-1 Network and Reverse Diabetic Kidney Disease.
    J Am Soc Nephrol. 2018 Feb 28. pii: ASN.2017101112. doi: 10.1681/ASN.2017101112.
    PubMed     Abstract available


    January 2018
  51. KIM Y, Lim JH, Kim MY, Kim EN, et al
    The Adiponectin Receptor Agonist AdipoRon Ameliorates Diabetic Nephropathy in a Model of Type 2 Diabetes.
    J Am Soc Nephrol. 2018 Jan 12. pii: ASN.2017060627. doi: 10.1681/ASN.2017060627.
    PubMed     Abstract available


    November 2017
  52. MOTTL AK, Gasim A, Schober FP, Hu Y, et al
    Segmental Sclerosis and Extracapillary Hypercellularity Predict Diabetic ESRD.
    J Am Soc Nephrol. 2017 Nov 27. pii: ASN.2017020192. doi: 10.1681/ASN.2017020192.
    PubMed     Abstract available


    October 2017
  53. WANG XX, Wang D, Luo Y, Myakala K, et al
    FXR/TGR5 Dual Agonist Prevents Progression of Nephropathy in Diabetes and Obesity.
    J Am Soc Nephrol. 2017 Oct 31. pii: ASN.2017020222. doi: 10.1681/ASN.2017020222.
    PubMed     Abstract available


  54. HARLAN SM, Heinz-Taheny KM, Sullivan JM, Wei T, et al
    Progressive Renal Disease Established by Renin-Coding Adeno-Associated Virus-Driven Hypertension in Diverse Diabetic Models.
    J Am Soc Nephrol. 2017 Oct 23. pii: ASN.2017040385. doi: 10.1681/ASN.2017040385.
    PubMed     Abstract available


  55. HINDEN L, Udi S, Drori A, Gammal A, et al
    Modulation of Renal GLUT2 by the Cannabinoid-1 Receptor: Implications for the Treatment of Diabetic Nephropathy.
    J Am Soc Nephrol. 2017 Oct 13. pii: ASN.2017040371. doi: 10.1681/ASN.2017040371.
    PubMed     Abstract available


    September 2017
  56. LIU Y, Li H, Liu J, Han P, et al
    Variations in MicroRNA-25 Expression Influence the Severity of Diabetic Kidney Disease.
    J Am Soc Nephrol. 2017 Sep 18. pii: ASN.2015091017. doi: 10.1681/ASN.2015091017.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Diabetes is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: